The 1st International GCP Workshop in Ho Chi Minh City, Vietnam (24-26 Sep 2010)
2010-07-26
GleneaglesCRC (Singapore) in collaboration with the Medical Research Centre (Vietnam) is conducting the very 1st International Good Clinical Practice Workshop.
This is an approved ICH-GCP Workshop by the Ministry of Health (MOH) Vietnam and being endorsed by Murdoch University, Western Australia.
The workshop is being held from 24-26 Sep 2010 at Oscar-Saigon Hotel, Ho Chi Minh City, Vietnam.
These 3-days Workshop will highlight upon the introduction to Clinical Research, principles of ICH-GCP, elements of Informed Consent, role of Ethics Committee, responsibility of Sponsor, Investigator & Study Monitor, handling of biological specimen, recruitment strategies and safety reporting, introduction to Bioavailability and Bioequivalence Studies.
For further info, kindly contact “Deny” at +62-21-5207739 or deny_l@gleneaglescrc.com and see the attached Flyer.
GCRC signs MOU with Clinical Trial Centre of Severance Hospital (South Korea)
2010-05-03
On 20th April 2010, Memorandum of Understanding (MOU) had been signed between GleneaglesCRC Pte Ltd (GCRC) and Clinical Trial Centre of Severance Hospital, Yonsei University Health System (SEVCTC) in South Korea.
SEVCTC its self, designated by the Korean Ministry of Health and WElface in 2005 as a Regional Clinical Trials Centre, and was granted the government fund for its establishment and operations, in addition to the contribution from Seoul City and 9 pharmaceutical companies.
Under the terms of the MOU, GCRC and SEVCTC intend to enter into a mutually beneficial cooperative relationship to provide comprehensive and high quality clinical research services to global pharmaceutical and biopharmaceutical companies. Both parties will embark on joint marketing efforts to promote each other’s services to these companies; SEVCTC will be GCRC’s preferred subcontractor for clinical research that are required to be conducted in South Korea, while GCRC will be SEVCTC’s preferred subcontractor for clinical research studies to be conducted in the Asia-Pacific region.
The ultimate goal of the centre is to improve medical care for the patients through enhancement of world-class quality clinical research activities. The centre aims to lead new drug development globally as well as domestically in collaboration with industry and regulatory bodies. It also ensures that the clinical studies are done in the most ethical and scientifically sounds ways to protect rights, safety and welfare of study participants.
A historical milestone between GleneaglesCRC Pte. Ltd. and Mistui & Co. Ltd.
2010-02-08
Mitsui & Co. Ltd. has acquired a slightly less than 50% interest and become an investor for GleneaglesCRC Pte. Ltd. for roughly 400 million Yen on 14th January 2010.
This would become a historical milestone for GCRC by having Mitsui as a 49% Stake-Holder, while the 51% Stake will belong to Parkway.
Mitsui is the 2nd largest trading company in Japan. In world wide, Mitsui has presence in every country in the world in a wide range of industries, i.e.: banking, textile, chemicals, consumer goods, telecommunication, aerospace, automobiles, properties, etc..
This would be the first time for Mitsui to invest into a CRO and it aims to use Mitsui’s capital participation as a springboard on expectations of growing demand for clinical trials in Asia.
Cancellation of PIEC Full-Board Meeting in December
2010-01-14
With effect from 1 February 2010, there will NOT be any convened meeting for Full-Board Review in December. Submissions received by PIEC from 1 November to 31 December will be tabled for Full-Board Meeting in January.
Please note that the 30-day review period will not be applicable for these submissions.
Please feel free to contact PIEC Secretariat at 6737 3642 or piec@gleneaglescrc.com for further information.
GCP-Workshop in Jakarta (3-4 Dec 2009)
2009-11-04
We proudly annouce that we are going to conduct a GCP (Good Clinical Practice) Workshop on 3-4 December 2009 at Borobudur Hotel, Jakarta - Indonesia.
This would be a 3rd event of GCRC in conjunction with RESPINA (Respiratory Care of Indonesia).
In this 2-day GCP workshop, you will be exposed to the theoretical and operational aspects of core Clinical Trials Management activities. We believe that it is important that participants will put what they are learning to use, and they will be evaluated on their knowledge through a GCP Test.
Participants who pass the test will receive a certificate exclusively issued by GleneaglesCRC Pte. Ltd, endorsed by Murdoch University, Western Australia.
Feel free to contact "Deny" at +62-21-5207739 or deny_l@gleneaglescrc.com for further info and detailed-Agenda.
Agenda
GCRC Wins BioSpectrum Award!
2009-03-05
GleneaglesCRC Is proud to be the winner of the BioSpectrum Asia Pacific Awards 2009 Editors Choice Emerging CRO Company of Singapore Award!
You can find more details about the BioSpectrum Asia Pacific Awards 2009 at the BioSpectrum website
You can also find an article written by our CEO, Dr Yap Kok Wei, on the successes and challenges that GleneaglesCRC has faced in conducting trials in Asia here.
GCP Workshop, May 2009
2009-03-16
We are glad to make our first announcement of the GCP Workshop event of 2009!
Backed by a fully subscribed GCP Workshop in Pantai Medical Centre in year 2008, GleneaglesCRC has put together another comprehensive 3-day ICH-GCP workshop. This year we’re adding more “oomph” into our workshop and it is themed:
GCP Idol: “Bring your Research Team to Stardom & Excel in Asia”
Key highlights
* Dual GCP Certification – Malaysian MOH & exclusive certificate endorsed by Murdoch University
* Speakers from Academia, Regulatory Agency, Research Hospital, Independent Ethics Committee, Pharmaceutical Industry and Clinical Research Organisation.
* Excellent location – Gleneagles Intan Medical Centre, Kuala Lumpur, Malaysia
Mark your calendars!
GCP Workshop: 22nd – 24th May 2009
Check back to download registration forms or email us at gcp2009my@gleneaglescrc.com to register today!
Main Organiser: Gleneagles Intan Medical Centre in association with GleneaglesCRC Pte Ltd
Co-Organiser: Parkway Health, Murdoch University, National University of Malaysia, Info Kinetics Sdn Bhd
Good Clinical Practice workshop
2008-07-16
GleneaglesCRC is conducting a Good Clinical Practice workshop at the Westin Resort Nusa Dua, Bali, 6-7 August 2008. Download the eflyers for more details!
Cover Page
Agenda
GleneaglesCRC Selects Phase Forwards Clintrial Product for Clinical Data Management
2006-10-10
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that GleneaglesCRC, an Asian-based contract research organization (CRO), has selected Phase Forwards Clintrial (TM) software for use in the CROs Clinical Data Management units in Singapore, the Philippines and China.Read Article
GleneaglesCRC is conducting Murdoch-accredited GCP Course
2008-04-24
GleneaglesCRC is now the only CRO offering ICH-GCP courses that are accredited by Murdoch University. The first of these courses will be held at the Pantai Medical Centre in Kuala Lumpur, Malaysia, from 30th May - 1st June 2008.
Parkway Holdings expands Shanghai presence with S$64m acquisition
2007-05-03
SINGAPORE: Healthcare services provider Parkway Holdings is expanding its presence in Shanghai. It has acquired a majority stake in the World Link Medical and Dental Centres by buying 100 per cent of another entity, Medical Resources International. Read Article
GleneaglesCRC Expands in Asia
2007-05-14
Seven-year-old GleneaglesCRC is garnering a lot of firsts lately. Last fall, the Singapore-based firm became the first contract research organization (CRO) to open an office in western Australia expressly for the purpose of marketing to U.S. and European drug companies that need to recruit lots of Caucasians. Also last year, it became the first CRO to open a data-management center in the Philippines. Last summer, it was the first CRO to set up operations in Indonesia.Read Article
GleneaglesCRC Perth Official Opening Ceremony
2006-10-06
GleneaglesCRC opens a regional office in Perth.